FDA expands access to a promising drug for one of the worst cancers The Washington Post
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer The New York Times
FDA green lights early access to pancreatic cancer drug, daraxonrasib USA Today
US FDA authorizes early access to Revolution’s pancreatic cancer pill Yahoo
Groundbreaking advancements in pancreatic cancer treatment excite UW Health doctor WKOW
FDA expands access to a promising drug for one of the worst cancers – The Washington Post
